Similar articles

• The great medicines scandal: access is not just about cost.

  Waning BJ. Waning BJ. BMJ. 2006 Jul 1;333(7557):44. doi: 10.1136/bmj.333.7557.44-a. BMJ. 2006. PMID: 16809717 Free PMC article. No abstract available.
• The concept of essential medicines: lessons for rich countries.

  Hogerzeil HV. Hogerzeil HV. BMJ. 2004 Nov 13;329(7475):1169-72. doi: 10.1136/bmj.329.7475.1169. BMJ. 2004. PMID: 15539676 Free PMC article. Review.
• No deal in sight on cheap drugs for poor countries.

  Fleck F. Fleck F. BMJ. 2003 Mar 1;326(7387):465. doi: 10.1136/bmj.326.7387.465/a. BMJ. 2003. PMID: 12609924 Free PMC article. No abstract available.
• EU agrees deal on cheaper drugs for developing world.

  Watson R. Watson R. BMJ. 2003 Jun 7;326(7401):1229. doi: 10.1136/bmj.326.7401.1229-a. BMJ. 2003. PMID: 12791716 Free PMC article. No abstract available.
• Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.

  Tetteh E. Tetteh E. Res Social Adm Pharm. 2009 Sep;5(3):286-97. doi: 10.1016/j.sapharm.2008.08.001. Epub 2009 Feb 3. Res Social Adm Pharm. 2009. PMID: 19733829 Review. No abstract available.